两种不同的响应性有机纳米载体,结合化疗和免疫疗法,对抗癌症
Maria Sancho-Albero1, Alessia Lucrezia Fenaroli1, Mirco Scaccaglia1
1Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Via Mario Negri, 2, Milan 20156, Italy.
ACS omega
|October 14, 2024
概括
这项研究引入了化学免疫疗法 (CIT) 的新型纳米载体,使得序列性药物输送能够向癌细胞和巨细胞. 这种方法在体外显著增强了瘤细胞死亡.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 化疗免疫疗法 (CIT) 结合了化疗和免疫疗法,以改善癌症治疗反应.
- 在CIT的关键挑战包括控制药物输送和选择性细胞吸收.
- 开发复杂的交付系统对于有效的CIT至关重要.
研究的目的:
- 开发一种对刺激有反应的纳米载体系统,用于连续递送化疗和免疫刺激药物.
- 为了实现癌细胞和巨细胞选择性吸收药物.
- 为了在体外评估这种双重药物输送策略的有效性.
主要方法:
- 使用不同的有机纳米载体 (纳米和纳米粒子),具有不同的形态和刺激反应.
- 封装的多克索鲁比辛在PEGylated纳米中用于瘤细胞的吸收,而在纳米颗粒中用于巨细胞的吸收.
- 顺序使用纳米载体来评估联合治疗效果.
主要成果:
- 已证明瘤细胞对多克索鲁比辛载荷纳米载体和巨细胞对雷西基莫德载荷纳米载体的优先吸收.
- 连续使用导致瘤细胞活力显著降低.
- 与单一药物治疗相比,结合化疗和免疫治疗的方法显示出更高的疗效.
结论:
- 开发了一种新的纳米载体战略,用于化学免疫治疗中的时空控制.
- 这种方法克服了CIT的关键挑战,使得有针对性的交付和增强的治疗结果.
- 这些发现支持这种纳米输送系统在先进癌症治疗中的潜力.
相关概念视频
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


